Modulation of IL-6 production during the menstrual cycle in vivo and in vitro

Brain, Behavior, and Immunity

Volumn 14, Issue 1, 2000, Pages 49-61

  Konecna, Leona ^a   Yan, Ming S ^a   Miller, Luitpold E ^a   Schölmerich, Jürgen ^a   Falk, Werner ^a   Straub, Rainer H ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Dehydroepiandrosterone; IL 6; Menstrual cycle; Testosterone; TNF; estradiol

Indexed keywords

ESTRADIOL; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PRASTERONE; SEX HORMONE; TESTOSTERONE;

ADULT; ARTICLE; FEMALE; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0034131264     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1006/brbi.1999.0570     Document Type: Article

References (35)

1. Arnbjornsson E. Acute appendicitis risk in various phases of the menstrual cycle. Acta Chir. Scand. 149:1983;603-605.
2. Bellido T., Jilka R. L., Boyce B. F., Girasole G., Broxmeyer H., Dalrymple S. A., Murray R., Manolagas S. C. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J. Clin. Invest. 95:1995;2886-2895.
3. Bunning R. A., Russell R. G., Van Damme J. Independent induction of interleukin 6 and prostaglandin E2 by interleukin 1 in human articular chondrocytes. Biochem. Biophys. Res. Commun. 166:1990;1163-1170.
4. Cannon J. G., Dinarello C. A. Increased plasma interleukin-1 activity in women after ovulation. Science. 227:1985;1247-1249.
5. Dinarello C. A., Cannon J. G., Wolff S. M., Bernheim H. A., Beutler B., Cerami A., Figari I. S., Palladino M. A. J., O'Connor J. V. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J. Exp. Med. 163:1986;1433-1450.
6. Driver H. S., Dijk D. J., Werth E., Biedermann K., Borbely A. A. Sleep and the sleep electroencephalogram across the menstrual cycle in young healthy women. J. Clin. Endocrinol. Metab. 81:1996;728-735.
7. Freeman E. W. Premenstrual syndrome: current perspectives on treatment and etiology. Curr. Opin. Obstet. Gynecol. 9:1997;147-153.
8. Girasole G., Jilka R. L., Passeri G., Boswell S., Boder G., Williams D. C., Manolagas S. C. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J. Clin. Invest. 89:1992;883-891.
9. Goldstein R., Duff S., Karsh J. Functional assessment and symptoms of rheumatoid arthritis in relation to menstrual cycle phase. J. Rheumatol. 14:1987;395-397.
10. Gonzalez-Hernandez J. A., Bornstein S. R., Ehrhart-Bornstein M., Gschwend J. E., Gwosdow A., Jirikowski G., Scherbaum W. A. IL-1 is expressed in human adrenal gland in vivo. Possible role in a local immune-adrenal axis. Clin. Exp. Immunol. 99:1995;137-141.
11. Gorai I., Taguchi Y., Chaki O., Kikuchi R., Nakayama M., Yang B. C., Yokota S., Minaguchi H. Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle. J. Clin. Endocrinol. Metab. 83:1998;326-332.
12. Guerne P. A., Carson D. A., Lotz M. IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J. Immunol. 144:1990;499-505.
13. Jilma B., Dimberger E., Loscher I., Rumplmayr A., Hildebrandt J., Eichler H. G., Kapiotis S., Wagner O. F. Menstrual cycle-associated changes in blood levels of interleukin-6, alpha 1 acid glycoprotein, and C-reactive protein. J. Lab. Clin. Med. 130:1997;69-75.
14. Kapas L., Krueger J. M. Tumor necrosis factor-beta induces sleep, fever, and anorexia. Am. J. Physiol. 263:1992;R703-R707.
15. Kassem M., Harris S. A., Spelsberg T. C., Riggs B. L. Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors. J. Bone Miner. Res. 11:1996;193-199.
16. Kutteh W. H., Rainey W. E., Carr B. R. Regulation of interleukin-6 production in human fetal Kupffer cells. Scand. J. Immunol. 33:1991;607-613.
17. Lahita R. G. The connective tissue diseases and the overall influence of gender. Int. J. Fertil. Menopausal Stud. 41:1996;156-165.
18. Latman N. S. Relation of menstrual cycle phase to symptoms of rheumatoid arthritis. Am. J. Med. 74:1983;957-960.
19. Leslie C. A., Dubey D. P. Increased PGE2 from human monocytes isolated in the luteal phase of the menstrual cycle. Implications for immunity? Prostaglandins. 47:1994;41-54.
20. Li Z. G., Danis V. A., Brooks P. M. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin. Exp. Rheumatol. 11:1993;157-162.
21. Ligthart G. J., Corberand J. X., Fournier C., Galanaud P., Hijmans W., Kennes B., Muller-Hermelink H. K., Steinmann G. G. Admission criteria for immunogerontological studies in man: The SENIEUR protocol. Mech. Ageing Dev. 28:1984;47-55.
22. McDonagh J. E., Singh M. M., Griffiths I. D. Menstrual arthritis. Ann. Rheum. Dis. 52:1993;65-66.
23. Padgett D. A., Loria R. M. In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol. J. Immunol. 153:1994;1544-1552.
24. Palnaes-Hansen C., Bulow S., Karlsen J. Tubocutaneous fistula in Crohn's disease. Case report. Acta Chir. Scand. 153:1987;465-466.
25. Philippeaux M. M., Piguet P. F. Expression of tumor necrosis factor-alpha and its mRNA in the endometrial mucosa during the menstrual cycle. Am. J. Pathol. 143:1993;480-486.
26. Polan M. L., Kuo A., Loukides J., Bottomly K. Cultured human luteal peripheral monocytes secrete increased levels of interleukin-1. J. Clin. Endocrinol. Metab. 70:1990;480-484.
27. Pottratz S. T., Bellido T., Mocharla H., Crabb D., Manolagas S. C. 17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J. Clin. Invest. 93:1994;944-950.
28. Ray A., Prefontaine K. E., Ray P. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J. Biol. Chem. 269:1994;12940-12946.
29. Rincon M., Anguita J., Nakamura T., Fikrig E., Flavell R. A. Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J. Exp. Med. 185:1997;461-469.
30. Shalaby M. R., Laegreid W. W., Ammann A. J., Liggitt H. D. Tumor necrosis factor-alpha-associated uterine endothelial injury in vivo. Influence of dietary fat. Lab. Invest. 61:1989;564-570.
31. Steinberg A. D., Steinberg B. J. Lupus disease activity associated with menstrual cycle [letter]. J. Rheumatol. 12:1985;816-817.
32. Straub R. H., Konecna L., Hrach S., Rothe G., Kreutz M., Scholmerich J., Falk W., Lang B. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J. Clin. Endocrinol. Metab. 83:1998;2012-2017.
33. Tabibzadeh S., Kong Q. F., Babaknia A., May L. T. Progressive rise in the expression of interleukin-6 in human endometrium during menstrual cycle is initiated during the implantation window. Hum. Reprod. 10:1995a;2793-2799.
34. Tabibzadeh S., Zupi E., Babaknia A., Liu R., Marconi D., Romanini C. Site and menstrual cycle-dependent expression of proteins of the tumour necrosis factor (TNF) receptor family, and BCL-2 oncoprotein and phase-specific production of TNF alpha in human endometrium. Hum. Reprod. 10:1995b;277-286.
35. Tsigos C., Papanicolaou D. A., Defensor R., Mitsiadis C. S., Kyrou I., Chrousos G. P. Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology. 66:1997;54-62.